Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Leach

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|September 3, 2015
DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrenceAaron M Horning, Julius A Awe, Chiou-Miin Wang, et al.
International Journal of Molecular Sciences|August 10, 2024
A Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Markers Using Proteograph<sup>TM</sup> and Trapped Ion Mobility Mass SpectrometryMatthew E K Chang, Jane Lange, Jessie May Cartier, et al.
Science Advances|July 29, 2021
Regulation of telomere homeostasis and genomic stability in cancer by <i>N</i> <sup>6</sup>-adenosine methylation (m<sup>6</sup>A)Ji Hoon Lee, Juyeong Hong, Zhao Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective CohortMichael A Liss, Nicole Zeltser, Yingye Zheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Validation of genome-wide prostate cancer associations in men of African descentBao-Li Chang, Elaine Spangler, Stephen Gallagher, et al.
Prostate Cancer|March 12, 2013
Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descentTimothy R Rebbeck, Susan S Devesa, Bao-Li Chang, et al.
International Journal of Cancer|September 15, 2020
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|September 3, 2015
DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrenceAaron M Horning, Julius A Awe, Chiou-Miin Wang, et al.
International Journal of Molecular Sciences|August 10, 2024
A Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Markers Using Proteograph<sup>TM</sup> and Trapped Ion Mobility Mass SpectrometryMatthew E K Chang, Jane Lange, Jessie May Cartier, et al.
Science Advances|July 29, 2021
Regulation of telomere homeostasis and genomic stability in cancer by <i>N</i> <sup>6</sup>-adenosine methylation (m<sup>6</sup>A)Ji Hoon Lee, Juyeong Hong, Zhao Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective CohortMichael A Liss, Nicole Zeltser, Yingye Zheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Validation of genome-wide prostate cancer associations in men of African descentBao-Li Chang, Elaine Spangler, Stephen Gallagher, et al.
Prostate Cancer|March 12, 2013
Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descentTimothy R Rebbeck, Susan S Devesa, Bao-Li Chang, et al.
International Journal of Cancer|September 15, 2020
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Pageof 13